REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that the 2020 update from the Global Initiative for Chronic ...

Please provide your email address to receive an email when new articles are posted on . Patients who received an endobronchial valve vs. lung volume reduction surgery had significantly heightened odds ...

Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...

An estimated 3.1 million Americans have been diagnosed with emphysema, the life-threatening condition most commonly associated with smoker's lung and long-term tobacco use. As a severe and related ...

PHOENIX - Banner University Medicine Lung Institute is the first in Arizona and second in the U.S. to offer a new lung valve treatment for patients with severe COPD or emphysema. Recently approved by ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that UnitedHealthcare®, the largest commercial insurer in the United ...

The FDA today approved the Zephyr endobronchial valve for treating breathing difficulty associated with severe emphysema, according to a press release. “Treatment options are limited for people with ...

David Feller-Kopman, MD, section chief, pulmonary and critical care medicine and Elliot D. Backer, MD, tend to Lucy Mary Kempe, the first patient to receive the Zephyr Valve at Dartmouth-Hitchcock ...

NORTH PHILADELPHIA (WPVI) -- Temple Health researchers are reporting success with a new minimally invasive treatment for emphysema. It would be an alternative to lung volume reduction surgery - one of ...

Lung volume reduction surgery (LVRS) involves the removal of damaged lung tissue, which can help people with lung damage breathe more easily. Doctors tend to recommend LVRS to people with severe ...